Evidence map›Paper›PMID 41608669›Full record

ArticleEuropean heart journal. Digital health2026

Impact of remote monitoring on well-being, therapeutic adherence, and organ damage evaluation in hypertensive patients: the PROSIT study.

Marialuisa S Marozzi, Vanessa Desantis, Francesco Corvasce, Giuseppe S Falcone, Marilena Santovito, Gianmarino Colleoni, Monica Montagnani, Angelo Vacca, Sebastiano Cicco

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marialuisa S MarozziUnit of Internal Medicine 'Guido Baccelli', Department of Precision and Regenerative Medicine and Ionian Area- (DiMePRe-J), University of Bari Aldo Moro, AUOC Policlinico, Piazza Giulio Cesare, 11, Bari 70124, Italy.
Vanessa DesantisUnit of Pharmacology, Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J), University of Bari Aldo Moro, Bari, Italy.
Francesco CorvasceUnit of Internal Medicine 'Guido Baccelli', Department of Precision and Regenerative Medicine and Ionian Area- (DiMePRe-J), University of Bari Aldo Moro, AUOC Policlinico, Piazza Giulio Cesare, 11, Bari 70124, Italy.
Giuseppe S FalconeUnit of Internal Medicine 'Guido Baccelli', Department of Precision and Regenerative Medicine and Ionian Area- (DiMePRe-J), University of Bari Aldo Moro, AUOC Policlinico, Piazza Giulio Cesare, 11, Bari 70124, Italy.
Marilena SantovitoExprivia SpA, Molfetta, Bari, Italy.
Gianmarino ColleoniSTMicroelectronics Srl, Unit of Lecce, Lecce, Italy.
Monica MontagnaniUnit of Pharmacology, Department of Precision and Regenerative Medicine and Ionian Area - (DiMePRe-J), University of Bari Aldo Moro, Bari, Italy.
Angelo VaccaUnit of Internal Medicine 'Guido Baccelli', Department of Precision and Regenerative Medicine and Ionian Area- (DiMePRe-J), University of Bari Aldo Moro, AUOC Policlinico, Piazza Giulio Cesare, 11, Bari 70124, Italy.
Sebastiano CiccoUnit of Internal Medicine 'Guido Baccelli', Department of Precision and Regenerative Medicine and Ionian Area- (DiMePRe-J), University of Bari Aldo Moro, AUOC Policlinico, Piazza Giulio Cesare, 11, Bari 70124, Italy.ORCID https://orcid.org/0000-0002-1980-5728

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: The PROSIT (Patient-Reported Outcomes and Smart-Imaging in Telecardiology) study aimed to evaluate the feasibility and potential clinical impact of remote patient monitoring in hypertension management, focusing on medication adherence, therapeutic optimization, and organ damage. Methods and results: We conducted a prospective single-center, randomized pilot study involving 100 hypertensive Caucasian patients, assigned to three groups: Group A, equipped with a wearable ECG device, and a mobile application reporting vital signs; Group B, using only the mobile app; and Group C (control), standard care. Blood pressure and heart rate were measured with validated devices. Medication adherence was assessed with the validated Medication Adherence Report Scale (MARS-5). Echocardiography and biochemical parameters were evaluated at baseline and after 12 months, including a 6-month washout period without digital support. Patients in Groups A and B showed significantly higher MARS-5 scores, vs. Group C ( Conclusion: This study suggests that telemedicine with remote monitoring may enhance medication adherence and allow early treatment optimization with fewer drugs, accompanied by favorable changes in cardiac and renal parameters. These findings warrant confirmation in larger, multicenter studies.

Indexed as

Arterial hypertensione-HealthHypertension-mediated organ damageRemote patient monitoringTelemedicine

Identifiers

PMID41608669
PMCPMC12835817

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.